BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15659348)

  • 1. GATA1 in normal and malignant hematopoiesis.
    Crispino JD
    Semin Cell Dev Biol; 2005 Feb; 16(1):137-47. PubMed ID: 15659348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
    Wechsler J; Greene M; McDevitt MA; Anastasi J; Karp JE; Le Beau MM; Crispino JD
    Nat Genet; 2002 Sep; 32(1):148-52. PubMed ID: 12172547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
    Greene ME; Mundschau G; Wechsler J; McDevitt M; Gamis A; Karp J; Gurbuxani S; Arceci R; Crispino JD
    Blood Cells Mol Dis; 2003; 31(3):351-6. PubMed ID: 14636651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.
    Gurbuxani S; Vyas P; Crispino JD
    Blood; 2004 Jan; 103(2):399-406. PubMed ID: 14512321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.
    Crispino JD
    Pediatr Blood Cancer; 2005 Jan; 44(1):40-4. PubMed ID: 15390312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA transcription factors in hematologic disease.
    Cantor AB
    Int J Hematol; 2005 Jun; 81(5):378-84. PubMed ID: 16158817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1.
    Li Z; Godinho FJ; Klusmann JH; Garriga-Canut M; Yu C; Orkin SH
    Nat Genet; 2005 Jun; 37(6):613-9. PubMed ID: 15895080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.
    Hitzler JK; Cheung J; Li Y; Scherer SW; Zipursky A
    Blood; 2003 Jun; 101(11):4301-4. PubMed ID: 12586620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome.
    Xu G; Nagano M; Kanezaki R; Toki T; Hayashi Y; Taketani T; Taki T; Mitui T; Koike K; Kato K; Imaizumi M; Sekine I; Ikeda Y; Hanada R; Sako M; Kudo K; Kojima S; Ohneda O; Yamamoto M; Ito E
    Blood; 2003 Oct; 102(8):2960-8. PubMed ID: 12816863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.
    Rainis L; Bercovich D; Strehl S; Teigler-Schlegel A; Stark B; Trka J; Amariglio N; Biondi A; Muler I; Rechavi G; Kempski H; Haas OA; Izraeli S
    Blood; 2003 Aug; 102(3):981-6. PubMed ID: 12649131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of GATA1 mutations in Down syndrome.
    Ahmed M; Sternberg A; Hall G; Thomas A; Smith O; O'Marcaigh A; Wynn R; Stevens R; Addison M; King D; Stewart B; Gibson B; Roberts I; Vyas P
    Blood; 2004 Apr; 103(7):2480-9. PubMed ID: 14656875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression regulation and domain function of hematopoietic GATA factors.
    Shimizu R; Yamamoto M
    Semin Cell Dev Biol; 2005 Feb; 16(1):129-36. PubMed ID: 15659347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A leukemogenic twist for GATA1.
    Look AT
    Nat Genet; 2002 Sep; 32(1):83-4. PubMed ID: 12172549
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mutations of erythroid/megakaryocytic transcription factor GATA-1 and leukemia in childhood].
    Ito E
    Rinsho Ketsueki; 2004 Feb; 45(2):108-14. PubMed ID: 15045818
    [No Abstract]   [Full Text] [Related]  

  • 15. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
    Ge Y; Stout ML; Tatman DA; Jensen TL; Buck S; Thomas RL; Ravindranath Y; Matherly LH; Taub JW
    J Natl Cancer Inst; 2005 Feb; 97(3):226-31. PubMed ID: 15687366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited thrombocytopenia due to GATA-1 mutations.
    Millikan PD; Balamohan SM; Raskind WH; Kacena MA
    Semin Thromb Hemost; 2011 Sep; 37(6):682-9. PubMed ID: 22102271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.
    Del Vecchio GC; Giordani L; De Santis A; De Mattia D
    Acta Haematol; 2005; 114(2):113-6. PubMed ID: 16103636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor GATA-1 and Down syndrome leukemogenesis.
    Muntean AG; Ge Y; Taub JW; Crispino JD
    Leuk Lymphoma; 2006 Jun; 47(6):986-97. PubMed ID: 16840187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
    Pine SR; Guo Q; Yin C; Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
    Leuk Res; 2005 Nov; 29(11):1353-6. PubMed ID: 15916804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1.
    Nichols KE; Crispino JD; Poncz M; White JG; Orkin SH; Maris JM; Weiss MJ
    Nat Genet; 2000 Mar; 24(3):266-70. PubMed ID: 10700180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.